Experimental esophageal patch trial halted after just one patient
Disease control
Terminated
This study tested a regenerative cell product placed on the wound after removing early-stage esophageal cancer. The goal was to prevent the esophagus from narrowing, a common complication. Only one person enrolled before the trial was stopped, so we have very little information a…
Phase: PHASE3 • Sponsor: CellSeed Inc. • Aim: Disease control
Last updated May 08, 2026 12:01 UTC